Home » View latest Diclofenac Tenders from India

View latest Diclofenac Tenders from India

TendersOnTime provides latest updates on Indian Diclofenac Tenders from various state and central government tendering authorities. The information on Diclofenac online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Diclofenac Sodium Sr 100 [(Ph No.:03015) Diclofenac Sodium Sr 100 Mg Tab/Cap.]

TOT Ref No.: 100077017

Deadline: 29 Apr 2024

Country: India

Diclofenac Pot. 50 Mg + Serratiopeptidas

TOT Ref No.: 100078926

Deadline: 29 Apr 2024

Country: India

Diclofenac Spray Minimum 50 G Can

TOT Ref No.: 100336713

Deadline: 10 May 2024

Country: India

10202, Diclofenac Suppository 100 Mg, Diclofenac Suppository 100 Mg, Qty: 300 Amp, (BOQ Item #8)

TOT Ref No.: 100238774

Deadline: 10 May 2024

Country: India

Supply of Diclofenac Sod. 50 mg Tab.

TOT Ref No.: 99173083

Deadline: 15 May 2024

Country: India

Thiocholchicoside 4 Mg + Diclofenac 50 Mg Tablet

TOT Ref No.: 100026211

Deadline: 30 Apr 2024

Country: India

10202, Diclofenac Sodium Suppository 100Mg, Diclofenac Sodium Suppository 100Mg, Qty: 3000 No, (BOQ

TOT Ref No.: 100189941

Deadline: 10 May 2024

Country: India

10258, Diclofenac 25 Mg and Ampule of 1 Ml, Diclofenac 25 Mg and Ampule of 1 Ml, Qty: 600 Amp, (BOQ

TOT Ref No.: 99958000

Deadline: 03 May 2024

Country: India

Diclofenac, Qty: 8700 NO, (BOQ Item #48)

TOT Ref No.: 100313305

Deadline: 13 May 2024

Country: India

Supply of Diclofenac Spray can of 50 ml Can Qty 200 At Panaji

TOT Ref No.: 99534334

Deadline: 30 Apr 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.